BCG-induced non-specific effects on heterologous infectious disease in Ugandan neonates: an investigator-blind randomised controlled trial

Prentice S, Nassanga B, Webb EL, Akello F, Kiwudhu F, Akurut H, Elliott AM, Arts RJW, Netea MG, Dockrell HM, Cose S, Prentice S
,
et al
No abstract available
Keywords:

3213 Paediatrics

,

32 Biomedical and Clinical Sciences

,

Clinical Research

,

Perinatal Period - Conditions Originating in Perinatal Period

,

Emerging Infectious Diseases

,

Rare Diseases

,

Clinical Trials and Supportive Activities

,

Infectious Diseases

,

Pediatric

,

6.1 Pharmaceuticals

,

Infection

,

BCG Vaccine

,

Communicable Diseases

,

Humans

,

Immunity, Innate

,

Incidence

,

Infant

,

Infant, Newborn

,

Morbidity

,

Tuberculosis

,

Uganda

,

Vaccination